Loss of the exon encoding the juxtamembrane domain is essential for the oncogenic activation of TPR-MET
Open Access
- 22 July 1999
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 18 (29), 4275-4281
- https://doi.org/10.1038/sj.onc.1202791
Abstract
TPR-MET, a transforming counterpart of the c-MET proto-oncogene detected in experimental and human cancer, results from fusion of the MET kinase domain with a dimerization motif encoded by TPR. In this rearrangement the exons encoding the Met extracellular, transmembrane and juxtamembrane domains are lost. The juxtamembrane domain has been suggested to be a regulatory region endowed with negative feedback control. To understand whether its absence is critical for the generation of the Tpr-Met transforming potential, we produced a chimeric molecule (Tpr-juxtaMet) with a conserved juxtamembrane domain. The presence of the domain (aa 962–1009) strongly inhibited Tpr-Met dependent cell transformation. Cell proliferation, anchorage-independent growth, motility and invasion were also impaired. The enzymatic behavior of Tpr-Met and Tpr-juxtaMet was the same, while Tpr-juxtaMet ability to associate cytoplasmic signal transducers and to elicit downstream signaling was severely impaired. These data indicate that the presence of the juxtamembrane domain counterbalances the Tpr-Met transforming potential and therefore the loss of the exon encoding the juxtamembrane domain is crucial in the generation of the active TPR-MET oncogene.Keywords
This publication has 24 references indexed in Scilit:
- Concomitant activation of pathways downstream of Grb2 and PI 3-kinase is required for MET-mediated metastasisOncogene, 1999
- Gab1 coupling to the HGF/Met receptor multifunctional docking site requires binding of Grb2 and correlates with the transforming potentialOncogene, 1997
- “Invasive-growth” signaling by the Met/HGF receptor: The hereditary renal carcinoma connectionBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1997
- Two Splice Variants of a Tyrosine Phosphatase Differ in Substrate Specificity, DNA Binding, and Subcellular LocationJournal of Biological Chemistry, 1996
- Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors.Journal of Clinical Investigation, 1996
- Specific Uncoupling of GRB2 from the Met ReceptorJournal of Biological Chemistry, 1996
- Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene ProductScience, 1991
- Tyrosine kinase receptor indistinguishable from the c-met proteinNature, 1989
- Mechanism of met oncogene activationCell, 1986
- Molecular cloning of a new transforming gene from a chemically transformed human cell lineNature, 1984